![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, November 20, 2023 10:38:26 AM
Value of Expertise: The shares were issued to a consultant whose expertise and involvement we believe are extremely valuable. The pricing reflects our confidence in the unique skills and experience they bring to our company.
Future Value Projection: We priced the shares with an eye towards the expected value in a year, considering the anticipated contributions of the consultant. This projection is part of a strategic plan aimed at enhancing our business model and, subsequently, our stock's value.
Documenting Potential: By valuing the shares at $0.25, we are documenting our belief in the potential value of the consultant's contribution and the expected growth trajectory of our company. This is not just a reflection of the current market price but a forward-looking assessment. This is optimistic and shows our goal, not a promise, of course.
Please note, the statements in this email regarding future events and projections are forward-looking statements. These statements are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. Factors that could cause or contribute to such differences include, but are not limited to, market conditions, the consultant's performance, changes in the industry, and broader economic factors. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
Recent MSRM News
- Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • InvestorsHub NewsWire • 06/05/2024 05:32:33 PM
- Mushrooms Inc. (OTC:MSRM) Launches New Health Supplements, Progresses with German Partnership, and Boosts Engagement Initiatives. • InvestorsHub NewsWire • 03/05/2024 02:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/08/2024 02:55:22 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/06/2024 05:18:40 PM
- Mushrooms Inc (OTC:MSRM) Announces Full Patent Filing for Groundbreaking Mycelium Technology Providing Bacterial Detection and Nutrient Delivery. • InvestorsHub NewsWire • 10/18/2023 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/14/2023 02:27:19 PM
- Mushrooms, Inc. (OTC: MSRM) Announces Diverse Business Development Team Assembled to Drive Company Growth. • InvestorsHub NewsWire • 08/23/2023 01:00:00 PM
- Mushrooms, Inc. (OTC: MSRM) is Poised for Textile Innovation and Global Impact as Full Patent Filing for Mycelium Thread Nears Completion. • InvestorsHub NewsWire • 08/08/2023 12:00:00 PM
- Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast. • InvestorsHub NewsWire • 07/19/2023 12:32:27 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM